J Biomol NMR (2008) 40:5564
Mounjaro is also a GLP-1 RA but slightly different in that it targets both GLP-1 (glucagon like peptide) and another hormone, GIP (glucagon dependent insulinotropic polypeptide)
Chemotherapy, in particular, can influence blood sugar levels, causing fluctuations that need careful consideration
Who should be considered for GLP-1/GIP Therapy
In addition, there were no differences in 30-day postoperative outcomes between patients who took a GLP-1 receptor agonist in the year before their surgery and those who did not, according to a presentation at the American College of Surgery Clinical Congress
Overall, that equated to a tiny decrease in density and no clear or statistically significant evidence of real bone loss